Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$123.74
À la fermeture: Aug 19 EDT
$124.47
0.730.59%
Pré-commercialisation: 4:08 AM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
e.l.f. Beauty Inc a un objectif de cours consensus de $124.88, basé sur les évaluations des 16 analystes. Le plus élevé est de $150 attribué par B. Riley Securities le juin 13, 2025, et le plus bas est de $75 attribué par DA Davidson le mars 19, 2025. Les 3 dernières évaluations d'analystes ont été publiées par Morgan Stanley, Canaccord Genuity et JP Morgan le août 11, 2025, août 7, 2025 et août 7, 2025. Avec un objectif de cours moyen de $130.67 entre Morgan Stanley, Canaccord Genuity et JP Morgan, il y a une variation implicite de 4.98% upside pour e.l.f. Beauty Inc à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
Morgan Stanley
Canaccord Genuity
JP Morgan
UBS
Goldman Sachs
1calculé à partir des notes des analystes
Notes d'analystes pour e.l.f. Beauty
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/11/2025 | 7.66% | Morgan Stanley | $114 → $134 | Upgrade | Equal-Weight → Overweight | |||
08/07/2025 | 2.84% | Canaccord Genuity | $150 → $128 | Maintains | Buy | |||
08/07/2025 | 4.44% | JP Morgan | $132 → $130 | Maintains | Overweight | |||
08/07/2025 | -10.02% | UBS | $120 → $112 | Maintains | Neutral | |||
08/07/2025 | 10.07% | Goldman Sachs | $120 → $137 | Maintains | Buy | |||
08/07/2025 | -8.41% | Morgan Stanley | $105 → $114 | Maintains | Equal-Weight | |||
07/25/2025 | 6.05% | JP Morgan | $123 → $132 | Maintains | Overweight | |||
07/17/2025 | -3.59% | UBS | $95 → $120 | Maintains | Neutral | |||
07/09/2025 | 20.51% | Canaccord Genuity | $114 → $150 | Maintains | Buy | |||
06/20/2025 | 8.46% | B of A Securities | $113 → $135 | Maintains | Buy | |||
06/13/2025 | 20.51% | B. Riley Securities | $110 → $150 | Maintains | Buy | |||
06/06/2025 | 4.44% | Truist Securities | $125 → $130 | Maintains | Buy | |||
06/06/2025 | 16.49% | Baird | $110 → $145 | Maintains | Outperform | |||
06/02/2025 | 4.44% | Raymond James | $105 → $130 | Maintains | Strong Buy | |||
05/30/2025 | 0.43% | Truist Securities | $75 → $125 | Maintains | Buy | |||
05/30/2025 | -1.18% | JP Morgan | $70 → $123 | Maintains | Overweight | |||
05/29/2025 | -9.22% | B of A Securities | $95 → $113 | Maintains | Buy | |||
05/29/2025 | -15.64% | Raymond James | $95 → $105 | Maintains | Strong Buy | |||
05/29/2025 | -12.43% | Piper Sandler | $81 → $109 | Maintains | Overweight | |||
05/29/2025 | -15.64% | Morgan Stanley | $70 → $105 | Maintains | Equal-Weight | |||
05/29/2025 | -7.61% | Jefferies | $75 → $115 | Maintains | Buy | |||
05/29/2025 | -8.41% | Canaccord Genuity | $105 → $114 | Maintains | Buy | |||
05/22/2025 | -23.68% | Raymond James | $85 → $95 | Maintains | Strong Buy | |||
05/21/2025 | -32.51% | UBS | $59 → $84 | Maintains | Neutral | |||
05/21/2025 | -23.68% | B of A Securities | $80 → $95 | Maintains | Buy | |||
05/14/2025 | -19.66% | Baird | $85 → $100 | Maintains | Outperform | |||
04/30/2025 | -34.92% | Piper Sandler | $90 → $81 | Maintains | Overweight | |||
04/24/2025 | -39.74% | Truist Securities | $100 → $75 | Maintains | Buy | |||
04/23/2025 | -39.74% | Jefferies | $175 → $75 | Maintains | Buy | |||
04/17/2025 | -52.6% | UBS | $74 → $59 | Maintains | Neutral | |||
04/17/2025 | -31.71% | Raymond James | $120 → $85 | Maintains | Strong Buy | |||
04/14/2025 | -31.71% | Baird | $110 → $85 | Maintains | Outperform | |||
04/11/2025 | -43.76% | JP Morgan | $127 → $70 | Maintains | Overweight | |||
03/31/2025 | -27.69% | Piper Sandler | $102 → $90 | Maintains | Overweight | |||
03/19/2025 | -39.74% | DA Davidson | $75 → $75 | Maintains | Neutral | |||
03/17/2025 | -39.74% | DA Davidson | $80 → $75 | Maintains | Neutral | |||
02/21/2025 | -0.38% | Goldman Sachs | $142 → $124 | Maintains | Buy | |||
02/18/2025 | -35.73% | DA Davidson | $80 → $80 | Maintains | Neutral | |||
02/07/2025 | -11.63% | Jefferies | $175 → $110 | Maintains | Buy | |||
02/07/2025 | -15.64% | Canaccord Genuity | $174 → $105 | Maintains | Buy | |||
02/07/2025 | 14.08% | Goldman Sachs | $165 → $142 | Maintains | Buy | |||
02/07/2025 | -27.69% | B. Riley Securities | $150 → $90 | Reiterates | Buy → Buy | |||
02/07/2025 | -3.59% | Raymond James | $175 → $120 | Maintains | Strong Buy | |||
02/07/2025 | -31.71% | Stifel | $105 → $85 | Maintains | Hold | |||
02/07/2025 | -18.05% | Piper Sandler | $131 → $102 | Reiterates | Overweight → Overweight | |||
02/07/2025 | -35.73% | DA Davidson | $170 → $80 | Downgrade | Buy → Neutral | |||
02/07/2025 | -40.55% | UBS | $158 → $74 | Downgrade | Buy → Neutral | |||
02/07/2025 | -43.76% | Morgan Stanley | $153 → $70 | Downgrade | Overweight → Equal-Weight | |||
02/05/2025 | 5.25% | Piper Sandler | $167 → $131 | Maintains | Overweight | |||
02/05/2025 | 36.58% | DA Davidson | $170 → $170 | Maintains | Buy | |||
02/03/2025 | -15.64% | Stifel | $115 → $105 | Maintains | Hold | |||
01/31/2025 | 39.79% | Canaccord Genuity | $200 → $174 | Maintains | Buy | |||
01/21/2025 | 36.58% | DA Davidson | $170 → $170 | Maintains | Buy | |||
01/16/2025 | 26.94% | UBS | $156 → $158 | Maintains | Buy | |||
01/16/2025 | 30.96% | JP Morgan | $154 → $163 | Maintains | Overweight | |||
01/13/2025 | 22.92% | Morgan Stanley | $139 → $153 | Upgrade | Equal-Weight → Overweight | |||
01/06/2025 | 34.17% | Piper Sandler | $165 → $167 | Maintains | Overweight | |||
12/23/2024 | 36.58% | DA Davidson | $170 → $170 | Maintains | Buy | |||
12/19/2024 | 36.58% | DA Davidson | $170 → $170 | Maintains | Buy | |||
12/18/2024 | 20.51% | Truist Securities | $130 → $150 | Maintains | Buy | |||
12/13/2024 | 32.56% | Goldman Sachs | → $165 | Initiates | → Buy | |||
12/12/2024 | 6.85% | Deutsche Bank | → $133 | Initiates | → Hold | |||
12/11/2024 | 36.58% | DA Davidson | $170 → $170 | Maintains | Buy | |||
11/29/2024 | 36.58% | DA Davidson | $170 → $170 | Maintains | Buy | |||
11/25/2024 | 36.58% | DA Davidson | $170 → $170 | Maintains | Buy | |||
11/12/2024 | 36.58% | DA Davidson | $170 → $170 | Maintains | Buy | |||
11/07/2024 | -7.61% | Stifel | $131 → $115 | Maintains | Hold | |||
11/07/2024 | 20.51% | B. Riley Securities | $175 → $150 | Maintains | Buy | |||
11/07/2024 | 60.68% | Canaccord Genuity | $250 → $200 | Maintains | Buy | |||
11/07/2024 | 23.72% | JP Morgan | $167 → $154 | Maintains | Overweight | |||
11/07/2024 | 32.56% | Piper Sandler | $162 → $165 | Reiterates | Overweight → Overweight | |||
11/07/2024 | 36.58% | DA Davidson | $223 → $170 | Maintains | Buy | |||
10/30/2024 | 40.6% | Jefferies | $220 → $175 | Maintains | Buy | |||
10/29/2024 | 79.16% | DA Davidson | $223 → $223 | Maintains | Buy | |||
10/24/2024 | 5.25% | Stifel | $161 → $131 | Maintains | Hold | |||
10/21/2024 | 40.6% | Baird | $240 → $175 | Maintains | Outperform | |||
10/16/2024 | 4.44% | Truist Securities | $210 → $130 | Maintains | Buy | |||
10/15/2024 | 32.56% | B of A Securities | $190 → $165 | Maintains | Buy | |||
10/15/2024 | 79.16% | DA Davidson | $223 → $223 | Maintains | Buy | |||
10/11/2024 | 34.17% | JP Morgan | $207 → $167 | Maintains | Overweight | |||
10/01/2024 | 79.16% | DA Davidson | $223 → $223 | Maintains | Buy | |||
09/30/2024 | 11.67% | Morgan Stanley | $184 → $139 | Maintains | Equal-Weight | |||
09/18/2024 | 79.16% | DA Davidson | $223 → $223 | Maintains | Buy | |||
09/16/2024 | 30.15% | Piper Sandler | $260 → $162 | Maintains | Overweight | |||
09/12/2024 | 20.51% | TD Cowen | $235 → $150 | Maintains | Buy | |||
09/11/2024 | 79.16% | DA Davidson | $223 → $223 | Maintains | Buy | |||
09/10/2024 | 40.6% | B. Riley Securities | → $175 | Initiates | → Buy | |||
09/09/2024 | 52.65% | B of A Securities | $230 → $190 | Maintains | Buy | |||
09/03/2024 | 79.16% | DA Davidson | $223 → $223 | Maintains | Buy | |||
08/29/2024 | 79.16% | DA Davidson | $223 → $223 | Maintains | Buy | |||
08/26/2024 | 108.89% | Piper Sandler | $260 → $260 | Maintains | Overweight | |||
08/09/2024 | 66.31% | JP Morgan | $224 → $207 | Maintains | Overweight | |||
08/09/2024 | 79.16% | DA Davidson | $220 → $223 | Maintains | Buy | |||
08/09/2024 | 84.78% | UBS | $250 → $230 | Maintains | Buy | |||
08/09/2024 | 108.89% | Piper Sandler | $258 → $260 | Reiterates | Overweight → Overweight | |||
08/09/2024 | 92.82% | Baird | $230 → $240 | Maintains | Outperform | |||
07/22/2024 | 88.8% | Raymond James | $235 → $235 | Maintains | Strong Buy | |||
07/22/2024 | 79.96% | JP Morgan | $182 → $224 | Maintains | Overweight | |||
07/22/2024 | 29.35% | Stifel | $151 → $161 | Maintains | Hold | |||
07/18/2024 | 84.78% | Baird | $210 → $230 | Upgrade | Neutral → Outperform |
FAQ
Quel est le cours indicatif de l'action e.l.f. Beauty (ELF) ?
Le dernier objectif de prix pour e.l.f. Beauty (NYSE:ELF) a été rapporté par Morgan Stanley le août 11, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $134.00 s'attendant à ce que ELF se rise dans les 12 prochains mois (un possible changement de 7.66% upside). 91 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour e.l.f. Beauty (ELF) ?
La dernière note d'analyste pour e.l.f. Beauty (NYSE:ELF) a été fournie par Morgan Stanley, et e.l.f. Beauty amélioré leur note overweight.
Quand a eu lieu la dernière mise à niveau pour e.l.f. Beauty (ELF) ?
La dernière amélioration pour e.l.f. Beauty Inc a eu lieu le août 11, 2025 lorsque Morgan Stanley a augmenté leur objectif de prix à $134. Morgan Stanley avait précédemment an equal-weight pour e.l.f. Beauty Inc.
Quand a eu lieu la dernière dégradation pour e.l.f. Beauty (ELF) ?
La dernière réduction pour e.l.f. Beauty Inc a eu lieu le février 7, 2025 lorsque DA Davidson a changé leur objectif de prix de $170 à $80 pour e.l.f. Beauty Inc.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour e.l.f. Beauty (ELF) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de e.l.f. Beauty, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour e.l.f. Beauty a été déposée le août 11, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers août 11, 2026.
La note d'analyste pour e.l.f. Beauty (ELF) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de e.l.f. Beauty (ELF) était un amélioré avec un objectif de prix de $114.00 à $134.00. Le prix actuel de e.l.f. Beauty (ELF) est de $124.47, ce qui est within la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.